InsiderTrades

Form 4 for EL Estée Lauder Companies (The)

Accepted 2023-02-14 00:00:00 ET · period of report 2023-02-13 · accession 0001001250-23-000015 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2023-02-14 2023-02-13 EL Haney Carl P. EVP Research Prod, Innovation M - OptEx $218.06 +9,741 14.5K +204% +$2.12M
D 2023-02-14 2023-02-13 EL Haney Carl P. EVP Research Prod, Innovation S - Sale+OE $253.90 -9,741 4,773 -67% -$2.47M
D 2023-02-14 2023-02-13 EL Haney Carl P. EVP Research Prod, Innovation M - OptEx $0.00 -9,741 4,871 -67% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2023-02-13 M A 9,741 $218.06 14,514 D — —
2 Common Class A Common Stock 2023-02-13 S D 9,741 $253.90 4,773 D — — (F1) The number of securities reported represents an aggregate number of shares sold in multiple open market transactions over a range of sales prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares sold by the Reporting Person at each separate price within the range. (F2) Sales prices range from $253.74 to $254.08 per share, inclusive.
3 Derivative Stock Option (Right to Buy) 2023-02-13 M D 9,741 $0.00 4,871 D $218.06 · — to 2030-09-03 9,741 Class A Common Stock (F4) Not applicable. (F3) Stock options granted pursuant to Fiscal 2002 Share Incentive Plan in respect of 4,870 shares exercisable from and after January 1, 2022; 4,871 shares exercisable from and after January 1, 2023; and 4,871 shares exercisable from and after January 1, 2024.